Barcelona, 14 November 2015: Mass prostate cancer (PSA) screening before the age of 55 may not have any benefit over screening starting after…

San Francisco, November 14, 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it will present 32 scientific presentations related to its…

November 12, 2015: Europe is the heaviest drinking region of the world, with consumption levels in some countries approximately twice the global average.

NOVEL diagnostic technology based on advanced self-learning computer algorithms may identify the source of cancer in a patient with 85% certainty…

FIRST self-propelled particles capable of delivering coagulants against the flow of blood have been developed to treat severe bleeding…

London, Wednesday 11 November 2015, 07:00 GMT: Norgine B.V. today announced new data showing that ENDOCUFF VISION®, a colonoscope device…

At the 2015 ESC congress in London UK, Aegerion Pharmaceuticals organized a satellite symposium in which three expert witnesses were cross examined on…

This meeting commenced with a talk from Prof Loibl on neoadjuvant and adjuvant strategies for HER2positive (human epidermal growth factor receptor…)

This engaging symposium focussed on the rationale and current evidence supporting the role for poly(adenosine diphosphate-ribose) polymerase (PARP)…

The METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma (RCC) was reported by Prof Choueiri at the European Cancer Congress…